DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling

Grigoriadis, A. E., Wang, Z., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,264

ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

Guermonprez, P., Saveanu, L., Kleijmeer, M. J., Davoust, J. M., Endert, P. V., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1741 · Cited by 693

Nuclear Factor of Activated T-cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking c-Fos

Matsuo, K., Galson, D. L., Chen, Z., Peng, L., Laplace, C., Wang, K. Z. Q., Bachler, M. A., Amano, H., Aburatani, H., Ishikawa, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313973200 · Cited by 570

Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.

Boyce, B. F., Yoneda, T., Lowe, C., Soriano, P. M., & Mundy, G. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116032 · Cited by 553

RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis

Kukita, T., Wada, N., Kukita, A., Kakimoto, T., Sandra, F., Toh, K., Nagata, K., Iijima, T., Horiuchi, M., Matsusaki, H., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040518 · Cited by 357

Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells.

(1995) · Europe PMC (PubMed Central) · Cited by 294

Bifurcation of osteoclasts and dendritic cells from common progenitors

Miyamoto, T. K., Ohneda, O., Arai, F., Iwamoto, K., Okada, S., Takagi, K., Anderson, D. M., & Suda, T. (2001) · Blood · doi:10.1182/blood.v98.8.2544 · Cited by 280

The emerging field of osteoimmunology

Mensah, K. A., Li, J., & Schwarz, E. M. (2009) · Immunologic Research · doi:10.1007/s12026-009-8093-x · Cited by 40

Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis

Lee, C.-C., Liu, F.-L., Chen, C., Chen, T., Chang, D., & Huang, H. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.015 · Cited by 40

Mechanism Underlying Post-menopausal Osteoporosis: HIF1α is Required for Osteoclast Activation by Estrogen Deficiency

Miyamoto, T. K. (2015) · The Keio Journal of Medicine · doi:10.2302/kjm.2015-0003-re · Cited by 39

Disulfiram Attenuates Osteoclast Differentiation In Vitro: A Potential Antiresorptive Agent

Ying, H., Qin, A., Cheng, T. S., Pavlos, N. J., Rea, S. L., Dai, K., & Zheng, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125696 · Cited by 39

Cell Fusion in Health and Disease

Dittmar, T., & Zänker, K. S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0763-4 · Cited by 41

Osteoclast biology in bone resorption: a review

Fu, C., & Shi, R. (2020) · STEMedicine · doi:10.37175/stemedicine.v1i4.57 · Cited by 39

Interleukin-1 Receptor-associated Kinase-4 (IRAK4) Promotes Inflammatory Osteolysis by Activating Osteoclasts and Inhibiting Formation of Foreign Body Giant Cells

Katsuyama, E., Miyamoto, H., Kobayashi, T., Sato, Y., Wu, H., Kanagawa, H., Fujie, A., Tando, T., Watanabe, R., Morita, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568360 · Cited by 39

Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division?

Maarsseveen, T. C. M. T. V., Vos, W., & van Diest, P. J. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03841.x · Cited by 39

Osteoclast biology in the single-cell era

Tsukasaki, M., & Takayanagi, H. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00213-x · Cited by 53

Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells

Yoshimura, Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.952 · Cited by 38

Dendritic Cell‐Specific Transmembrane Protein (DC‐STAMP) Regulates Osteoclast Differentiation via the Ca2+/NFATc1 Axis

Chiu, Y. G., Schwarz, E. M., Li, D., Xu, Y., Sheu, T., Li, J., Bentley, K. L. D. M., Feng, C., Wang, B., Wang, J., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25638 · Cited by 39

Identification of Novel Transcription Factors in Osteoclast Differentiation Using Genome-wide Analysis of Open Chromatin Determined by DNase-seq

Inoue, K., & Imai, Y. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2229 · Cited by 39

New Roles for Osteoclasts in Bone

Boyce, B. F., Yao, Z., Zhang, Q., GUO, R., Lu, Y., Schwarz, E. M., & Xing, L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.084 · Cited by 40

The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function

Sawatani, Y., Miyamoto, T. K., Nagai, S., Maruya, M., Imai, J., Miyamoto, K., Fujita, N., Ninomiya, K., Suzuki, T., Iwasaki, R., et al. (2008) · International Immunology · doi:10.1093/intimm/dxn082 · Cited by 38

Erratum to: Transforming Growth Factor b1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression

Zhao, H., Zhang, J., Shao, H., Liu, J., Jin, M., Chen, J., & Huang, Y. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.1303 · Cited by 38

SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion

Zhou, Y., Mohan, A. J., Moore, D. C., Lin, L., Zhou, F. L., Cao, J., Wu, Q., Qin, Y., Reginato, A. M., Ehrlich, M. G., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-260844 · Cited by 38

Alternative macrophage activation in periprosthetic osteolysis

Purdue, P. E. (2008) · Autoimmunity · doi:10.1080/08916930701694626 · Cited by 37

Altered bone remodeling in psoriatic arthritis

Mensah, K. A., Schwarz, E. M., & Ritchlin, C. T. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0050-5 · Cited by 35

The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells

Gurt, I., Artsi, H., Cohen‐Kfir, E., Hamdani, G., Ben-Shalom, G., Feinstein, B., El-Haj, M., & Dresner–Pollak, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134391 · Cited by 37

PIDD1 in cell cycle control, sterile inflammation and cell death

Weiler, E. S., Szabo, T., Garcia-Carpio, I., & Villunger, A. (2022) · Biochemical Society Transactions · doi:10.1042/bst20211186 · Cited by 23

Regulation of Osteoclast Multinucleation by the Actin Cytoskeleton Signaling Network

Takito, J., Otsuka, H., Yanagisawa, N., Arai, H., Shiga, M., Inoue, M., Nonaka, N., & Nakamura, M. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24723 · Cited by 37

Elevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent Mice

Beier, E. E., Holz, J. D., Sheu, T., & Puzas, J. E. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv234 · Cited by 37

Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis

Zhu, X. Y., Gao, J., Ng, P. Y., Qin, A., Steer, J. H., Pavlos, N. J., Zheng, M., Dong, Y., & Cheng, T. S. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2710 · Cited by 36

Mitf regulates osteoclastogenesis by modulating NFATc1 activity

Lu, S.-Y., Li, M., & Lin, Y. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.018 · Cited by 37

Role of actin filaments in fusopod formation and osteoclastogenesis

Wang, Y., Brooks, P. J., Jang, J. J., Silver, A. S., Arora, P. D., McCulloch, C. A., & Glogauer, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.001 · Cited by 36

Critical Role of MKP-1 in Lipopolysaccharide-Induced Osteoclast Formation through CXCL1 and CXCL2

Valerio, M., Herbert, B., Basilakos, D. S., Browne, C., Yu, H.-G., & Kirkwood, K. (2014) · Cytokine · doi:10.1016/j.cyto.2014.08.007 · Cited by 38

Approximating bone ECM: Crosslinking directs individual and coupled osteoblast/osteoclast behavior

Hwang, M. P., Subbiah, R., Kim, I. G., Lee, K. E., Park, J., Kim, S., & Park, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.052 · Cited by 36

DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption

Wisitrasameewong, W., Kajiya, M., Movilă, A., Rittling, S. R., Ishii, T., Suzuki, M., Matsuda, S., Mazda, Y., Ruiz‐Torruella, M., Azuma, M. M., et al. (2017) · Journal of Dental Research · doi:10.1177/0022034517690490 · Cited by 36

A Cell Fusion-Based Screening Method Identifies Glycosylphosphatidylinositol-Anchored Protein Ly6e as the Receptor for Mouse Endogenous Retroviral Envelope Syncytin-A

Bacquin, A., Bireau, C., Tanguy, M., Romanet, C., Vernochet, C., Dupressoír, A., & Heidmann, T. (2017) · Journal of Virology · doi:10.1128/jvi.00832-17 · Cited by 36

Nano‐Roughness‐Mediated Macrophage Polarization for Desired Host Immune Response

Dabare, P. R. L., Bachhuka, A., Quek, J. Y., Marsal, L. F., Hayball, J. D., & Vasilev, K. A. (2023) · Small Science · doi:10.1002/smsc.202300080 · Cited by 36

Prostaglandin E2 and Its Receptor EP2 Modulate Macrophage Activation and Fusion in Vitro

Saleh, L. S., Vanderheyden, C., Frederickson, A., & Bryant, S. J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01180 · Cited by 35

Cell surface-bound La protein regulates the cell fusion stage of osteoclastogenesis

Whitlock, J. M., Leikina, E., Melikov, K., de Castro, L. F., Mattijssen, S., Maraia, R. J., Collins, M. T., & Chernomordik, L. (2023) · Nature Communications · doi:10.1038/s41467-023-36168-x · Cited by 36

Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine

Leger, A. J., Altobelli, A., Mosquea, L. M., Belanger, A. J., Song, A., Cheng, S. H., Jiang, C., & Yew, N. S. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0171-6 · Cited by 35

Evolution of programmed cell fusion: Common mechanisms and distinct functions

Oren‐Suissa, M., & Podbilewicz, B. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22284 · Cited by 35

Bone-protective Functions of Netrin 1 Protein

Maruyama, K., Kawasaki, T., Hamaguchi, M., Hashimoto, M., Furu, M., Ito, H., Fujii, T., Takemura, N., Karuppuchamy, T., Kondo, T., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738518 · Cited by 36

Important roles of PI3Kγ in osteoclastogenesis and bone homeostasis

Kang, H., Chang, W., Hurley, M. M., Vignery, A., & Wu, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001499107 · Cited by 35

Dehydrodiconiferyl Alcohol Inhibits Osteoclast Differentiation and Ovariectomy-Induced Bone Loss through Acting as an Estrogen Receptor Agonist

Lee, W., Ko, K. R., Kim, H.-K., Lee, D. S., Nam, I.-J., Lim, S., & Kim, S. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00927 · Cited by 33

Myosins in Osteoclast Formation and Function

Lee, B. S. (2018) · Biomolecules · doi:10.3390/biom8040157 · Cited by 33

miRNAs in osteoclast biology

Weivoda, M. M., Lee, S., & Monroe, D. G. (2020) · Bone · doi:10.1016/j.bone.2020.115757 · Cited by 34

Phospholipase Cγ2 is required for basal but not oestrogen deficiency–induced bone resorption

Kertész, Z., Győri, D., Körmendi, S., Fekete, T., Kis‐Tóth, K., Jakus, Z., Schett, G. A., Rajnavölgyi, É., Dobó‐Nagy, C., & Mócsai, A. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02556.x · Cited by 33

Role of osteoclasts in regulating hematopoietic stem and progenitor cells

Miyamoto, T. K. (2013) · World Journal of Orthopedics · doi:10.5312/wjo.v4.i4.198 · Cited by 37

The potential of cell fusion for human therapy

Sullivan, S. K., & Eggan, K. C. (2006) · Stem Cell Reviews and Reports · doi:10.1007/bf02698061 · Cited by 33

The Loss of Cbl-Phosphatidylinositol 3-Kinase Interaction Perturbs RANKL-mediated Signaling, Inhibiting Bone Resorption and Promoting Osteoclast Survival

Adapala, N. S., Barbe, M. F., Langdon, W. Y., Nakamura, M. C., Tsygankov, A. Y., & Sanjay, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124628 · Cited by 32

New roles of filopodia and podosomes in the differentiation and fusion process of osteoclasts

Song, R., Liu, X. Z., Zhu, J., Zhang, J. M., Gao, Q., Zhao, H., Sheng, A., Yuan, Y., Gu, J., Zou, H., et al. (2014) · Genetics and Molecular Research · doi:10.4238/2014.july.2.7 · Cited by 33

Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling

Lee, J., Son, H. S., Lee, H. I., Lee, G., Jo, Y.-J., Hong, S.-E., Kim, N., Kwon, M., Kim, N. Y., Kim, H. J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800866rr · Cited by 35

Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse

Xiong, Q., Jiao, Y., Hasty, K. A., Canale, S. T., Stuart, J. M., Beamer, W. G., Deng, H., Baylink, D. J., & Gu, W. (2009) · Genomics · doi:10.1016/j.ygeno.2008.12.008 · Cited by 33

Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation

Quach, D., Parameswaran, N., McCabe, L. R., & Britton, R. A. (2019) · Bone Reports · doi:10.1016/j.bonr.2019.100227 · Cited by 31

Mechanisms of sperm-egg interactions emerging from gene-manipulated animals

Okabe, M., & Cummins, J. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7037-7 · Cited by 32

Effect of interferon-γ on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts

Kim, J.-W., Lee, M.-S., Lee, C.-H., Kim, H.-Y., Chae, S.-U., Kwak, H.-B., & Oh, J. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.5.281 · Cited by 32

Modified Salicylanilide and 3-Phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione Derivatives as Novel Inhibitors of Osteoclast Differentiation and Bone Resorption

Chen, C., Liu, F.-L., Lee, C.-C., Chen, T., Ali, A., Sytwu, H., Chang, D., & Huang, H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5007897 · Cited by 32

Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis

Lin, Y., Zhao, Y., Zhang, H., Hao, W.-J., Zhu, R.-D., Wang, Y., Hu, W. M., & Zhou, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997621 · Cited by 31

Mevalonates Restore Zoledronic Acid–induced Osteoclastogenesis Inhibition

Nagaoka, Y., Kajiya, H., Ozeki, S., Ikebe, T., & Okabe, K. (2014) · Journal of Dental Research · doi:10.1177/0022034514564187 · Cited by 33

Genetic determinants of Paget's disease of bone

Ralston, S. H., & Albagha, O. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06228.x · Cited by 31

Ellagic acid inhibits RANKL-induced osteoclast differentiation by suppressing the p38 MAP kinase pathway

Rantlha, M., Sagar, T., Kruger, M. C., Coetzee, M., & Deepak, V. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0790-0 · Cited by 31

Transglutaminase activity regulates differentiation, migration and fusion of osteoclasts via affecting actin dynamics

Sun, H., & Kaartinen, M. T. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26603 · Cited by 31

Dendritic Cells in Cancer

Salter, R. D., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4 · Cited by 32

Regulation of Osteoclast Differentiation by Myosin X

Tasca, A. W., Astleford, K., Lederman, A., Jensen, E. D., Lee, B. S., Gopalakrishnan, R., & Mansky, K. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07855-9 · Cited by 30

Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency‐induced bone mass loss by modulating TRAF6‐mediated signaling

Hu, B., Sun, X., Yang, Y., Ying, Z., Meng, J., Zhou, C., Jiang, G., Li, S., Wu, F., Zhao, X., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800920r · Cited by 30

Inhibition of STAT5A promotes osteogenesis by DLX5 regulation

Lee, K.-M., Park, K. H., Hwang, J. S., Lee, M., Yoon, D. S., Ryu, H. A., Jung, H. S., Park, K. W., Kim, J., Park, S. W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1184-7 · Cited by 30

The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF‐κB and CD9/gp130/STAT3 signalling pathway

Hu, J., Li, X., Chen, Y., Han, X., Li, L., Yang, Z., Duan, L., Lu, H., & He, Q. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14885 · Cited by 30

Epigenetic Regulators Involved in Osteoclast Differentiation

Astleford, K., Campbell, E., Norton, A., & Mansky, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197080 · Cited by 27

Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways

Li, X., Jiang, J., Yang, Z., Jin, S., Lu, X., & Qian, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16430 · Cited by 30

Impaired activity of the fusogenic micropeptide Myomixer causes myopathy resembling Carey-Fineman-Ziter syndrome

Ramirez-Martinez, A., Zhang, Y., van den Boogaard, M. H., McAnally, J., Rodríguez-Caycedo, C., Chai, A. C., Chemello, F., Massink, M. P. G., Cuppen, I., Elferink, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159002 · Cited by 30

Increased IL-6 Expression in Osteoclasts Is Necessary But Not Sufficient for the Development of Paget's Disease of Bone

Teramachi, J., Zhou, H., Subler, M. A., Kitagawa, Y., Galson, D. L., Dempster, D. W., Windle, J. J., Kurihara, N., & Roodman, G. D. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2158 · Cited by 32

Claudin‐1, Claudin‐2 and Claudin‐11 Genes Differentially Associate with Distinct Types of Anti‐inflammatory Macrophages In vitro and with Parasite‐ and Tumour‐elicited Macrophages In vivo

van den Bossche, J., Laoui, D., Morias, Y., Movahedi, K., Raes, G., Baetselier, P. D., & Ginderachter, J. V. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02689.x · Cited by 31

Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2

Kwon, J., Jin, W. J., Kim, B.-J., Kim, H., & Lee, Z. H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.053 · Cited by 31

Symmetrical retrograde actin flow in the actin fusion structure is involved in osteoclast fusion

Takito, J., Otsuka, H., Inoue, S., Kawashima, T., & Nakamura, M. (2017) · Biology Open · doi:10.1242/bio.025460 · Cited by 29

Bcl6 promotes osteoblastogenesis through Stat1 inhibition

Fujie, A., Funayama, A., Miyauchi, Y., Sato, Y., Kobayashi, T., Kanagawa, H., Katsuyama, E., Wu, H., Tando, T., Watanabe, R., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.012 · Cited by 29

Mechanotransduction via a TRPV4-Rac1 signaling axis plays a role in multinucleated giant cell formation

Arya, R. K., Goswami, R., & Rahaman, S. O. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014597 · Cited by 28

The pathophysiology of immunoporosis: innovative therapeutic targets

Ferbebouh, M., Vallières, F., Benderdour, M., & Fernandes, J. (2021) · Inflammation Research · doi:10.1007/s00011-021-01484-9 · Cited by 31

New Insights into the Mechanisms and Roles of Cell–Cell Fusion

Shinn-Thomas, J. H., & Mohler, W. A. (2011) · International review of cytology · doi:10.1016/b978-0-12-386039-2.00005-5 · Cited by 29

Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways

Hsiao, H.-B., Lin, H., Wu, J.-B., & Lin, W. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2199-z · Cited by 29

Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB

Kim, W.-S., Kim, H. J., Lee, Z. H., Lee, Y., & Kim, H.-H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.12.004 · Cited by 29

Differentiation of osteoclast precursors on gellan gum-based spongy-like hydrogels for bone tissue engineering

Maia, F. R., Musson, D. S., Naot, D., da Silva, L. P., Bastos, A. R., Costa, J. B., Oliveira, J. M., Correlo, V. M., Reis, R. L., & Cornish, J. (2018) · Biomedical Materials · doi:10.1088/1748-605x/aaaf29 · Cited by 29

Bone-Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both?

Silvestris, F., Ciavarella, S., Matteo, M. D., Tucci, M., & Dammacco, F. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0087 · Cited by 29

The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts

Matsubara, T., Kokabu, S., Nakatomi, C., Kinbara, M., Maeda, T., Yoshizawa, M., Yasuda, H., Takano-Yamamoto, T., Baron, R., & Jimi, E. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00425-17 · Cited by 28

Immunomodulatory hydrogels for tissue repair and regeneration

Liu, X., Hu, Y., Ju, Y., Yang, P. S., Shen, N., Yang, A., Wu, R., Fang, B., & Liu, L. (2024) · APL Materials · doi:10.1063/5.0228692 · Cited by 32

Cell fusion dynamics: mechanisms of multinucleation in osteoclasts and macrophages

Sabe, H., Yahara, Y., & Ishii, M. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00360-3 · Cited by 26

Genetics of Paget’s disease of bone

Albagha, O. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.125 · Cited by 29

HDL impairs osteoclastogenesis and induces osteoclast apoptosis via upregulation of ABCG1 expression

Huang, X., Lv, Y., He, P., Wang, Z., Xiong, F., He, L.-H., Zheng, X., Zhang, D., Cao, Q., & Tang, C. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy081 · Cited by 28

MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling.

Yin, Y., Tang, L., Chen, J., & Lu, X. (2017) · PubMed Central · Cited by 28

Group 2 innate lymphoid cells in bone marrow regulate osteoclastogenesis in a reciprocal manner via RANKL, GM-CSF and IL-13

Momiuchi, Y., Motomura, Y., Suga, E., Mizuno, H., Kikuta, J., Morimoto, A., Mochizuki, M., Otaki, N., Ishii, M., & Moro, K. (2021) · International Immunology · doi:10.1093/intimm/dxab062 · Cited by 28

Melatonin Attenuates RANKL-Induced Osteoclastogenesis via Inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 Signaling Pathways

Kim, S.-S., Jeong, S.-P., Park, B.-S., & Kim, I. (2022) · Molecules · doi:10.3390/molecules27020501 · Cited by 30

Regulatory Cross Talks of Bone Cells, Hematopoietic Stem Cells and the Nervous System Maintain Hematopoiesis

Kollet, Ó., Canaani, J., Kalinkovich, A., & Lapidot, T. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812800392760 · Cited by 30

Lipid raft–associated stomatin enhances cell fusion

Lee, J., Hsieh, C., Liu, H., Chen, C., Wu, S. T., Chen, T., Hsu, C., Liao, Y., Yang, C., Shyu, J., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600643r · Cited by 28

Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression

Zou, B., Tan, Y., Deng, W., Zheng, J., Yang, Q. Z., Ke, M., Ding, Z., & Li, X. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0477-4 · Cited by 30

Plectranthus amboinicusAttenuates Inflammatory Bone Erosion in Mice with Collagen-induced Arthritis by Downregulation of RANKL-induced NFATc1 Expression

Hsu, Y.-C., Cheng, C.-P., & Chang, D. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.101223 · Cited by 28

IFT80 negatively regulates osteoclast differentiation via association with Cbl-b to disrupt TRAF6 stabilization and activation

Deepak, V., Yang, S., Li, Z., Li, X., Ng, A. Y. H., Xu, D., Li, Y., Oursler, M. J., & Yang, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201490119 · Cited by 27

G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function

Nakano, S., Inoue, K., Xu, C., Deng, Z., Syrovatkina, V., Vitone, G., Zhao, L., Huang, X., & Zhao, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-40974-z · Cited by 30

IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95

Kim, H., Takegahara, N., Walsh, M. C., Middleton, S. A., Yu, J., Shirakawa, J., Ueda, J., Fujihara, Y., Ikawa, M., Ishii, M., et al. (2020) · Bone Research · doi:10.1038/s41413-019-0080-9 · Cited by 27

Genetic Determinants of Paget’s Disease of Bone

Makaram, N. S., & Ralston, S. H. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00676-w · Cited by 30

Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway

Wu, X., Zhao, K., Fang, X., Lu, F., Zhang, W., Song, X., Chen, L., Sun, J., & Chen, H. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s334421 · Cited by 27

Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation: A study to elucidate the action points of acidosis and search for putative target molecules

Kato, K., & Morita, I. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.062 · Cited by 26

OS9 interacts with DC-STAMP and modulates its intracellular localization in response to TLR ligation

Jansen, B., Eleveld-Trancikova, D., Sanecka-Duin, A., Hout-Kuijer, M. A. V., Hendriks, I. A. M., Looman, M. W. G., Leusen, J. H. W., & Adema, G. J. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.032 · Cited by 27

Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization

Kanemoto, S., Kobayashi, Y., Yamashita, T., Miyamoto, T. K., Cui, M., Asada, R., Cui, X., Hino, K., Kaneko, M., Takai, T., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.176057 · Cited by 27

Macrophages: The Bad, the Ugly, and the Good in the Inflammatory Response to Biomaterials

Scatena, M., Eaton, K. V., Jackson, M. F., Lund, S. A., & Giachelli, C. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45433-7_3 · Cited by 27

Sulforaphane inhibits osteoclast differentiation by suppressing the cell-cell fusion molecules DC-STAMP and OC-STAMP

Takagi, T., Inoue, H., Takahashi, N., Katsumata-Tsuboi, R., & Uehara, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.075 · Cited by 27

Vitexin suppresses RANKL‐induced osteoclastogenesis and prevents lipopolysaccharide (LPS)‐induced osteolysis

Jiang, J., Jia, Y., Lu, X., Zhang, T., Zhao, K., Fu, Z., Pang, C., & Qian, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28378 · Cited by 27

Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

Lee, C.-C., Liu, F.-L., Chen, C., Chen, T., Liu, F., Ali, A., Chang, D., & Huang, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.007 · Cited by 27

(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation

Chiou, W., Huang, Y., & Liu, Y.-W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089159 · Cited by 26

Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells

Yagi, M., Miyamoto, T. K., Toyama, Y., & Suda, T. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0697-9 · Cited by 121

The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity

Miyamoto, T. (2006) · Modern Rheumatology · doi:10.1007/s10165-006-0524-0 · Cited by 62

Dendritic cell-specific transmembrane protein (DC-STAMP) regulates bone metabolism through cell-cell fusion of osteoclasts

Iwasaki, R., Miyamoto, T. K., Asoda, S., Nakagawa, T., & Kawana, H. (2009) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2009.03.606

Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells

Miyamoto, H., Suzuki, T., Miyauchi, Y., Iwasaki, R., Kobayashi, T., Sato, Y., Miyamoto, K., Hoshi, H., Hashimoto, K., Yoshida, S., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1575 · Cited by 177

COMMENTARY Macrophage fusion: the making of osteoclasts and giant cells

Vignery, A. (2013)